Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Equity ETF median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Jan 2022 – 20 Aug 2026, limited by Mirae Asset Nifty India Manufacturing ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Nifty India Manufacturing ETF | Nifty 500 |
|---|---|---|
| 28 Jan 2022 | ₹100.00 | ₹100.00 |
| 16 Jun 2022 | ₹91.92 | ₹88.90 |
| 02 Nov 2022 | ₹109.45 | ₹105.26 |
| 20 Mar 2023 | ₹101.17 | ₹97.24 |
| 06 Aug 2023 | ₹123.92 | ₹114.72 |
| 23 Dec 2023 | ₹138.59 | ₹129.42 |
| 10 May 2024 | ₹167.46 | ₹139.03 |
| 25 Sep 2024 | ₹200.48 | ₹165.53 |
| 11 Feb 2025 | ₹167.18 | ₹142.30 |
| 30 Jun 2025 | ₹188.66 | ₹160.41 |
| 16 Nov 2025 | ₹199.42 | ₹161.90 |
| 03 Apr 2026 | ₹184.29 | ₹142.21 |
| 20 Aug 2026 | ₹215.37 | ₹159.70 |
| Metric | Mirae Asset NAV ₹168.12 Very High risk ★★★★☆ | Category median Equity ETF · 66 funds |
|---|---|---|
| +14.02% | +3.95% | |
| +20.18% | +11.55% | |
| — | +10.41% | |
| — | +11.81% | |
| +18.33% | +8.19% | |
| +18.53% | — | |
| +21.82% | +13.71% | |
| — | +14.22% | |
| — | +12.98% | |
| Risk | ||
| 15.97% | 17.16% | |
| 0.86 | 0.22 | |
| 1.18 | 0.32 | |
| -23.17% | -20.98% | |
| Nifty 500 | — | |
| +7.07% | +0.65% | |
| 1.03 | 1.00 | |
| 126.0% | 101.0% | |
| 97.0% | 97.0% | |
| 0.52% | 0.37% | |
| ₹248.93Cr | ₹91.02Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| 28 Jan 2022 | — | |
| 76 | — | |
| 38.1% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.